Skip to main content
Equibles
IVF logo

IVF · INVO Fertility, Inc. · Metrics

Track IVF — free

Use IVF with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IVF.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.60 +0.00 (+0.10%) At close · Oct 20
Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These factors, among others, raise substantial doubt about the Company's ability to continue as a going concern for at least one year from the date the accompanying financial statements are issued.”
View the 10-Q filed Aug 14, 2026
Market Cap
$1.51M
Shares
2.51M
Volume · Oct 20 68.71K Avg daily vol (3M) 2.13M

IVF metrics

65 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.60
Market cap
$1.51M

Price action

20 metrics
Price change (1W)
-17.2%
Price change (30D)
-37.3%
Price change (3M)
-42.2%
Price change (6M)
-73.6%
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
180.5%
Annualized volatility (3M)
135.8%
Beta
0.6
RSI (14D)
25.0
Price vs SMA 50
-36.1%
Price vs SMA 200
—
Avg volume (3M)
2.13M
Relative volume
0.0
Average dollar volume
$3.13M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
2.51M

Valuation

12 metrics
P / E (TTM)
0.0
Trailing earnings · reciprocal yield 602,411.0%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.2×
reciprocal yield 538.8%
P / book
0.1
reciprocal yield 1,179.8%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-497.3%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
30.8×
reciprocal yield 3.2%
EV / revenue historical average (5Y)
30.8×
reciprocal yield 3.2%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-17

Profitability

9 metrics
Gross margin
—
Operating margin
-78.7%
Trailing 12 months
Net margin
-92.3%
Gross profit (TTM)
$668,507
Operating profit (TTM)
−$5.93M
Net income (TTM)
−$6.95M
Trailing 12 months
Diluted EPS (TTM)
$3,620.49
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
$1,568.52
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$2,379.17
Book value per share
$9.16

Growth

11 metrics
Revenue growth YoY
+16.7%
Year over year
Net income growth YoY
—
Revenue (TTM)
$7.53M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+25,987.2%
Year over year · more shares
Revenue CAGR (3Y)
+102.6%
Revenue CAGR (5Y)
+45.8%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-42.1%
Return on assets
-26.9%
Debt / equity
0.1
Current ratio
0.7
EBITDA (TTM)
−$5.37M
Free cash flow (TTM)
—
Quick ratio
0.7
Interest coverage
-6.5
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$1.96M
Total assets
$25.83M
Total debt
$1.64M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$4.77M
Capital expenditures (TTM)
$39,456
R&D (TTM)
$265,663
SG&A (TTM)
$8.02M
Stock compensation (TTM)
$1.23M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
9
13F filer change QoQ
+1
Institutional ownership
5.2%
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
0.0%
Active holders' share change QoQ
-25.3%
Holder tenure
1.0
Price vs estimated holder cost
+5.3%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.6%

Short interest

3 metrics
Short interest
2.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
39 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1417926 CUSIP 44984F880 13F (30d) 2 filings 2 filers Visit website Investor relations